Evidence map›Paper›PMID 30565319›Full record

ReviewEquine veterinary journal2019

Serum amyloid A in equine health and disease.

O D Witkowska-Piłaszewicz, M Żmigrodzka, A Winnicka, A Miśkiewicz, K Strzelec, A Cywińska

Open access · bronzeAbstract readReview
In one paragraph

Review in Equine veterinary journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

O D Witkowska-PiłaszewiczDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, WarsawUniversity of Life Sciences - SGGW, Warsaw, Poland.
M ŻmigrodzkaDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, WarsawUniversity of Life Sciences - SGGW, Warsaw, Poland.
A WinnickaDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, WarsawUniversity of Life Sciences - SGGW, Warsaw, Poland.
A MiśkiewiczDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, WarsawUniversity of Life Sciences - SGGW, Warsaw, Poland.
K StrzelecDepartment of Horse Breeding and Use, University of Life Sciences in Lublin, Lublin, Poland.
A CywińskaDepartment of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, WarsawUniversity of Life Sciences - SGGW, Warsaw, Poland.ORCID https://orcid.org/0000-0002-5365-9218
Warsaw University of Life Sciences · PLUniversity of Life Sciences in Lublin · PL

Funding

KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Sade Food" 05-1/KNOW2/2015
6 · The paper itself

Abstract

Serum amyloid A (SAA) is the major acute phase protein in horses. It is produced during the acute phase response (APR), a nonspecific systemic reaction to any type of tissue injury. In the blood of healthy horses, SAA concentration is very low, but it increases dramatically with inflammation. Due to the short half-life of SAA, changes in its concentration in blood closely reflect the onset of inflammation and, therefore, measurement of SAA useful in the diagnosis and monitoring of disease and response to treatment. Increases in SAA concentration have been described in equine digestive, reproductive and respiratory diseases and following surgical procedures. Moreover, SAA has proven useful for detection of some subclinical pathologies that can disturb training and competing in equine athletes. Increasing availability of diagnostic tests for both laboratory and field use adds to SAA's applicability as a reliable indicator of horses' health status. This review article presents the current information on changes in SAA concentrations in the blood of healthy and diseased horses, focussing on clinical application of this biomarker.

Indexed as

AnimalsBiomarkersHorse DiseasesHorsesInflammationSerum Amyloid A ProteinBiomarkersSerum Amyloid A Proteinacute phase proteinsacute phase reactionhorseinflammatory diseasesSAA

Identifiers

PMID30565319
PMCPMC7163734
OpenAlexW2904220599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.